Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10966985 Macrocyclic compounds as ROS1 kinase inhibitors

Patent 10966985 was granted and assigned to Array Biopharma Inc. on April, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 12 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 12 Dec, 2023
Edits made to:
Article (+80 characters)
Article

Patent abstract

Methods for inhibiting a ROS1 kinase with compounds of Formula I:

Edits on 21 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 21 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=1096698500
Edits on 25 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Apr, 2023
Edits on 1 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 1 Apr, 2023
Edits on 28 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Sep, 2022
Edits on 26 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Edits on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Edits on 18 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 18 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10966985
Edits on 11 Feb, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 11 Feb, 2022
Edits made to:
Infobox (+12 properties)
‌

 US Patent 10966985 Macrocyclic compounds as ROS1 kinase inhibitors

Infobox
Is a
Patent
Patent
Patent applicant
Array Biopharma Inc.
Array Biopharma Inc.
Current assignee
Array Biopharma Inc.
Array Biopharma Inc.
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10966985
Date of patent
April 6, 2021
Patent application number
16199818
Date Filed
November 26, 2018
Patent citations
‌
US Patent 10030005 Inhibitors of RET
‌
US Patent 10137127 Liquid formulations of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-A]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide
‌
US Patent 10172861 Crystalline form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-A]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate
Patent primary examiner
‌
Savitha M Rao

Find more entities like US Patent 10966985 Macrocyclic compounds as ROS1 kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo